Research Featured
John Greenspan, BDS, PhD: 1938 – 2023
Dr. Greenspan's research career spanned more than five decades and included numerous groundbreaking discoveries in the field of oral medicine. He was particularly interested in the relationship between oral health and HIV/AIDS, and his work helped establish the field of oral HIV/AIDS research.
Throughout his career and until the very end of his life, Dr. Greenspan remained a devoted teacher and mentor, inspiring and guiding generations of dental and medical investigators. He supervised or mentored over 120 physicians and dental scientists. He was generous with his guidance and advice to those he mentored.
Courtesy of: University of California San Francisco | School of Dentistry
VIDEO
Study explains why HIV sometimes persists in blood post-treatment
Johns Hopkins University | June 8, 2026
News Updates
HIV and Aging: NIH Research Funding Opportunities
NIH | July 16, 2026
BioNTech advances mRNA therapeutic HIV vaccine into randomized Phase I/II trial
allsci | July 16, 2026
Experimental cell therapy delivers encouraging results for patients with rare, potentially fatal brain infection
UT MD Anderson Cancer Center | July 10, 2026
New virus catalogue reveals which pathogens pose the greatest threat
Gavi | July 6, 2026
Johns Hopkins scientists develop nose spray DNA vaccine for tuberculosis
ScienceDaily | July 4, 2026
Hefty New Study Takes on Weight Conundrum in HIV Care—and Its Answers Are Complicated
The BodyPro | July 1, 2026
Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies
Nature | June 30, 2026
New HIV vaccine shows unprecedented success in primate studies
News-Medical | June 30, 2026
JID for Clinicians: Frailty outcomes in people with HIV, immune checkpoint inhibition in chronic HBV infection and more
IDSA | June 29, 2026
A new gene editing approach shields the immune system from HIV
Fred Hutchinson Cancer Center | June 29, 2026
NIH Budget Cuts Threaten HIV Research
Think Global Health | June 26, 2026
“We Know It’s Possible”: The Future of HIV Cure Research
POZ | June 25, 2026
Federal Health Department Aims to Strengthen Clinical Research and Boost Trial Participation
POZ | June 24, 2026
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
The New England Journal of Medicine | June 24, 2026
“We Know It’s Possible” The Future of HIV Cure Research
amfAR | June 23, 2026
Supercharging T-Cells Against HIV’s Weak Spots: A New HIV Vaccine Study Reveals New Hope—and New Challenges—for Aging Patients
UNC School of Medicine / Institute for Global Health and Infectious Diseases | June 8, 2026
About HIV and the Center for Drug Evaluation and Research's role
USFDA | June 8, 2026
HIV, Brain Health Research, and How It Could Benefit Everyone
amfAR | May 28, 2026
Experimental HIV vaccine achieves a long-sought goal
Scripps Research | May 28, 2026
Broccoli compounds may help repair HIV-linked gut damage, animal study suggests
MedicalXpress | May 25, 2026
A Single Infusion Could Suppress H.I.V. for Years, Study ...
The New York Times | May 11, 2026
Future Directions for NIH HIV Research: A Look Ahead to 2026
The Journal of Infectious Diseases | May 15, 2026
University Seminar: Developing an HIV/AIDS Clinical Trials Unit in Collaboration with the Community
GWU.edu | May 21, 2026
Small study hints that revving up immune cells might help fight HIV
AP | May 12, 2026
Centers for AIDS Research (CFAR)
NIH | May 8, 2026
Advances in Immune-Based Approaches for the Cure of HIV Infection
Springer | May 2, 2026
A novel gene-therapy approach to ‘functionally cure’ HIV succeeds in some monkeys
Science Advisor | April 29, 2026
Trump Cuts Threaten to Halt Two Decades of HIV Vaccine Research
The Assembly | April 29, 2026
HIV Vaccine Research (AIDS Vaccine Research)
La Jolla Institute | April 23, 2026
Virological outcomes of PWH who discontinued cabotegravir/rilpivirine long-acting therapy in a real-world context
NIH | April 15, 2026
UNC Researchers Demonstrate Drug’s Effectiveness in Drawing Out Dormant HIV from Immune Cells
UNC | April 10, 2026
amfAR Launches $2 Million AI-Enabled, Collaborative Study to Map the HIV Reservoir
amfAR | April 8, 2026
